Scholar Rock Holding Corp - Common Stock (SRRK)
CUSIP: 80706P103
Q4 2024 13F Holders as of 31 Dec 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 102,846,929
- Total 13F shares
- 104,353,902
- Share change
- +15,023,752
- Total reported value
- $4,510,154,731
- Put/Call ratio
- 65%
- Price per share
- $43.22
- Number of holders
- 222
- Value change
- +$721,146,778
- Number of buys
- 142
- Number of sells
- 77
Quarterly Holders Quick Answers
What is CUSIP 80706P103?
CUSIP 80706P103 identifies SRRK - Scholar Rock Holding Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 80706P103:
Top shareholders of SRRK - Scholar Rock Holding Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
|
Company |
15%
|
14,114,029
|
$462,516,730 | $0 | 31 Dec 2024 | |
| Invus Public Equities, L.P. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
9,250,005
|
$385,262,708 | — | 10 Dec 2024 | |
| Invus Global Management, LLC |
13D/G
|
Invus Public Equities, L.P. |
11%
|
10,825,013
|
$354,735,676 | $0 | 31 Dec 2024 | |
| Redmile Group, LLC |
13D/G
13F
|
Company |
9.9%
|
9,885,124
|
$323,935,513 | $0 | 31 Dec 2024 | |
| Samsara BioCapital GP, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
6,788,609
|
$108,133,716 | — | 16 Oct 2023 | |
| Siren, L.L.C. |
3/4/5
13F
|
10%+ Owner · Individual |
11%
from 13F
|
11,259,438
|
$101,166,050 | — | 25 Jul 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
8.4%
|
8,654,106
|
$69,320,000 | — | 30 Sep 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
6.6%
|
6,788,609
|
$54,376,758 | — | 30 Sep 2024 | |
| BlackRock, Inc. |
13F
|
Company |
6%
|
6,155,464
|
$49,305,270 | — | 30 Sep 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
4,034,665
|
$32,317,668 | — | 30 Sep 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
2.9%
|
2,940,672
|
$23,554,783 | — | 30 Sep 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.7%
|
2,773,516
|
$22,215,863 | — | 30 Sep 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
2,409,207
|
$19,297,748 | — | 30 Sep 2024 | |
| Hood River Capital Management LLC |
13F
|
Company |
2.3%
|
2,349,721
|
$18,821,265 | — | 30 Sep 2024 | |
| Bellevue Group AG |
13F
|
Company |
2.1%
|
2,161,203
|
$17,311,236 | — | 30 Sep 2024 | |
| NORGES BANK |
13F
|
Company |
1.7%
|
1,730,104
|
$13,858,133 | — | 30 Sep 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.5%
|
1,543,025
|
$12,361,498 | — | 30 Sep 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.4%
|
1,399,202
|
$11,207,608 | — | 30 Sep 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.1%
|
1,155,536
|
$9,255,429 | — | 30 Sep 2024 | |
| Nagesh K. Mahanthappa |
3/4/5
|
Interim CEO and President |
—
mixed-class rows
|
530,491
mixed-class rows
|
$7,653,597 | — | 16 Jun 2022 | |
| Clearbridge Investments, LLC |
13F
|
Company |
0.9%
|
924,395
|
$7,404,407 | — | 30 Sep 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.76%
|
783,474
|
$6,275,627 | — | 30 Sep 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
0.73%
|
750,000
|
$6,007,500 | — | 30 Sep 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.73%
|
748,489
|
$5,995,397 | — | 30 Sep 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.72%
|
742,300
|
$5,945,823 | — | 30 Sep 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.71%
|
734,019
|
$5,879,491 | — | 30 Sep 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.69%
|
709,831
|
$5,685,746 | — | 30 Sep 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.65%
|
670,342
|
$5,369,439 | — | 30 Sep 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
620,623
|
$4,971,190 | — | 30 Sep 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.6%
|
618,914
|
$4,957,501 | — | 30 Sep 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.58%
|
592,000
|
$4,741,920 | — | 30 Sep 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.53%
|
547,723
|
$4,387,261 | — | 30 Sep 2024 | |
| BIT Capital GmbH |
13F
|
Company |
0.51%
|
521,845
|
$4,179,978 | — | 30 Sep 2024 | |
| Yung H. Chyung |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
295,996
mixed-class rows
|
$4,117,505 | — | 14 Feb 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
502,793
|
$4,027,372 | — | 30 Sep 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.4%
|
408,281
|
$3,270,331 | — | 30 Sep 2024 | |
| AXA S.A. |
13F
|
Company |
0.36%
|
372,355
|
$2,982,564 | — | 30 Sep 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.3%
|
313,467
|
$2,510,870 | — | 30 Sep 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.27%
|
278,775
|
$2,433,706 | — | 30 Sep 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.27%
|
273,340
|
$2,386,258 | — | 30 Sep 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.28%
|
289,138
|
$2,315,996 | — | 30 Sep 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.27%
|
275,000
|
$2,202,750 | — | 30 Sep 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.27%
|
273,520
|
$2,190,898 | — | 30 Sep 2024 | |
| Gregory John Carven |
3/4/5
|
Chief Scientific Officer |
—
mixed-class rows
|
173,708
mixed-class rows
|
$2,042,187 | — | 16 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.24%
|
248,736
|
$1,994,751 | — | 30 Sep 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.24%
|
244,605
|
$1,959,286 | — | 30 Sep 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
233,300
|
$1,868,733 | — | 30 Sep 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.21%
|
216,585
|
$1,734,846 | — | 30 Sep 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.21%
|
212,862
|
$1,705,024 | — | 30 Sep 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.19%
|
199,777
|
$1,600,213 | — | 30 Sep 2024 |
Institutional Holders of Scholar Rock Holding Corp - Common Stock (SRRK) as of Q4 2024
As of 31 Dec 2024,
Scholar Rock Holding Corp - Common Stock (SRRK) was held by
222 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
104,353,902 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, Siren, L.L.C., BlackRock, Inc., Samsara BioCapital, LLC, VANGUARD GROUP INC, Redmile Group, LLC, MARSHALL WACE, LLP, Polar Capital Holdings Plc, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
222
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
160
Q4 2024 holders
222
Holder diff
62
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 Value $ | Q4 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.